A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines.

ABSTRACT: Since the outbreak of the novel coronavirus disease 2019 (COVID-19) in Wuhan, China, many health care systems have been heavily engaged in treating and preventing the disease, and the year 2020 may be called as "historic COVID-19 vaccine breakthrough". Due to the COVID-19 pandemic, many companies have initiated investigations on developing an efficient and safe vaccine against the virus. From Moderna and Pfizer in the United States to PastocoVac in Pasteur Institute of Iran and the University of Oxford in the United Kingdom, different candidates have been introduced to the market. COVID-19 vaccine research has been facilitated based on genome and structural information, bioinformatics predictions, epitope mapping, and data obtained from the previous developments of severe acute respiratory

SUBMITTER: Abdolmaleki G 

PROVIDER: S-EPMC9436716 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature